IDIX
NasdaqGS
0.000.00 (0.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.00
Open0.00
Bid0.00 x
Ask0.00 x
52wk Range
Day's Range0.00 - 0.00
Volume0
Avg Vol (3m)N/A
  • American City Business Journals10 days ago

    Here's where Merck's new Cambridge research facility will be located

    The new microbiome research site in Cambridge planned by Merck & Co. will be at the 50,000-square-foot former facility of Idenix Pharmaceuticals, which the New Jersey-based drug giant acquired in 2014. A company spokeswoman did not say how many employees would be at the new early discovery research facility. The spokeswoman said the facilty, first reported late Tuesday , it will open in “late 2016.” The person who will oversee it — Daria Hazuda, Merck’s head of Infectious Diseases and Vaccines discovery research — will split her time between Cambridge and Merck’s facility in West Point, Pa.

  • Motley Foollast year

    3 Important Questions We Want Answered When Merck Reports Its Q2 Results

    Big Pharma Merck is scheduled to report its second-quarter earnings results on July 28. Here are three questions investors are expecting to have answered on that date.